{"nct_id":"NCT03019588","title":"Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063)","status":"TERMINATED","status_verified_date":"2022-06","start_date":"2017-02-16","start_date_type":"ACTUAL","primary_completion_date":"2021-06-29","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}